03635nam a22005775i 4500001001800000003000900018005001700027007001500044008004100059020003700100024003500137050001400172072001700186072002300203072001600226245018500242250001800427264007200445300006500517336002600582337002600608338003600634347002400670505076800694520059101462650001802053650002002071650003002091650003102121650003602152650002702188650003202215650002702247650002002274650003002294650004102324700008502365700008402450700009402534700009002628700008002718710003402798773002602832776003602858776003602894776003602930856004602966912001403012912001403026999001703040978-981-97-3001-8DE-He21320251030112610.0cr nn 008mamaa240702s2024    si |    s    |||| 0|eng d  a97898197300189978-981-97-3001-87 a10.1007/978-981-97-3001-82doi 4aRC261-271 7aMJCL2bicssc 7aMED0620002bisacsh 7aMJCL2thema10aBiosimilars for Cancer Treatmenth[electronic resource] :bA Promising Approach /cedited by Shvetank Bhatt, Harish Dureja, Samir Gunvantbhai Patel, Archita Samir Patel, Kamal Dua.  a1st ed. 2024. 1aSingapore :bSpringer Nature Singapore :bImprint: Springer,c2024.  aXVI, 309 p. 25 illus., 24 illus. in color.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 a1. An Overview of Biosimilars -- 2. Immunobiology of Cancer -- 3. Mechanism of Biosimilars for the treatment of Cancer -- 4. Biosimilars in Colorectal Cancer -- 5. Biosimilars in Cervical Caner -- 6. Biosimilars in Prostate Cancer -- 7. Biosimilars in Gastric Cancer -- 8. Biosimilars in Lung Cancer -- 9. A Recent Overview of The Growing Applications of Biosimilars in Pancreatic Cancer Management- Current Picture and Future Perspectives -- 10. Biosimilars in Breast Cancer -- 11. Biosimilars in Hepatocellular Carcinoma -- 12. Biosimilars in Ovarian Cancer -- 13. Biosimilars in Blood Cancer -- 14. Biosimilars in Clinical Trials -- 15. Regulatory Considerations of Biosimilars in Cancer -- 16. Future Scope of Biosimilars for the Treatment of Various Cancers.  aThe book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment. 0aCancer.94311 0aBiology.968861 0aCancerxTreatment.963722 0aCancerxPrevention.979933 0aCancerxGenetic aspects.97350114aCancer Biology.96782924aBiological Sciences.96886524aCancer Therapy.97341424aCancers.97120324aCancer Prevention.97993424aCancer Genetics and Genomics.9735021 aBhatt, Shvetank.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9734161 aDureja, Harish.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9799351 aGunvantbhai Patel, Samir.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9799361 aSamir Patel, Archita.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9799371 aDua, Kamal.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9734212 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978981973000108iPrinted edition:z978981973002508iPrinted edition:z978981973003240uhttps://doi.org/10.1007/978-981-97-3001-8  aZDB-2-SBL  aZDB-2-SXB  c61292d61292